Suppression of macrophage infiltration inhibits activation of hepatic stellate cells and liver fibrogenesis in rats

被引:147
作者
Imamura, M
Ogawa, T
Sasaguri, Y
Chayama, K
Ueno, H
机构
[1] Univ Occupat & Environm Hlth, Sch Med, Dept Biochem & Mol Pathol, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan
[2] Hiroshima Univ, Dept Med & Mol Sci, Grad Sch Biomed Sci, Hiroshima, Japan
[3] Univ Occupat & Environm Hlth, Sch Med, Dept Pathol & Cell Biol, Kitakyushu, Fukuoka 8078555, Japan
关键词
D O I
10.1053/j.gastro.2004.10.005
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background& Aims: Monocytes/ macro phages infiltrate into injured livers. We tried to clarify their roles in inflammation and subsequent fibrogenesis by inhibiting their infiltration with a mutated form (7ND; 7 amino acids at the N-terminal were deleted) of monocyte chemoattractant protein :1, which may function as a dominant-negative mutant. Methods: Rats were injected via the tail vein with an adenovirus expressing either human 7ND (Ad7ND), a truncated type II transforming growt factor beta receptor (AdTbeta-TR), which works as a dominant-negative receptor, bacterial beta-galactosidase (AdLacZ), or saline. Seven days later, the rats were treated with dimethyinitrosamine for 1-21 days. Results: Within 24 hours after a single dimethyinitrosamine injection, macrophages were observed in livers. With a 3-day dimethylnitrosamine treatment, activated hepatic stellate cells were detectable in livers in AdLacZ-, AdTbeta-TR-, and saline-injected rats. In contrast, in the Ad7ND-treated rats, infiltration of macrophages was markedly reduced, and activated hepatic stellate cells were not detectable. After a 3-week dimethyinitrosamine treatment, fibrogenesis was almost completely inhibited, and activated hepatic stellate cells were hardly seen in livers in both Ad7ND- and AdTbeta-TR-treated rats. Conclusions: Our results show that blockade of macrophage infiltration inhibits activation of hepatic stellate cells and leads to suppression of liver fibrogenesis. The presence of activated hepatic stellate cells in the initial phase after injury and its absence at a later phase in the AdTbeta-TRtreated livers indicate that transforming growth factor beta is not an activating factor for hepatic stellate cells, and this suggests that transforming growth factor beta is required for the survival of activated hepatic stellate cells. Our study suggests that infiltrated macrophages may themselves produce an activating factor for hepatic stellate cells.
引用
收藏
页码:138 / 146
页数:9
相关论文
共 33 条
[1]   Chemokines and leukocyte traffic [J].
Baggiolini, M .
NATURE, 1998, 392 (6676) :565-568
[2]   MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1) EXPRESSION OCCURS IN TOXIC RAT-LIVER INJURY AND HUMAN LIVER-DISEASE [J].
CZAJA, MJ ;
GEERTS, A ;
XU, J ;
SCHMIEDEBERG, P ;
JU, Y .
JOURNAL OF LEUKOCYTE BIOLOGY, 1994, 55 (01) :120-126
[3]   Importance of monocyte chemoattractant protein-1 pathway in neointimal hyperplasia after periarterial injury in mice and monkeys [J].
Egashira, K ;
Zhao, QW ;
Kataoka, C ;
Ohtani, K ;
Usui, M ;
Charo, IF ;
Nishida, K ;
Inoue, S ;
Katoh, M ;
Ichiki, T ;
Takeshita, A .
CIRCULATION RESEARCH, 2002, 90 (11) :1167-1172
[4]   Serum concentrations and peripheral secretion of the beta chemokines monocyte chemoattractant protein 1 and macrophage inflammatory protein 1α in alcoholic liver disease [J].
Fisher, NC ;
Neil, DAH ;
Williams, A ;
Adams, DH .
GUT, 1999, 45 (03) :416-420
[5]  
FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828
[6]   Costimulation of fibroblast collagen and transforming growth factor beta(1) gene expression by monocyte chemoattractant protein-1 via specific receptors [J].
GharaeeKermani, M ;
Denholm, EM ;
Phan, SH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (30) :17779-17784
[7]   Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice [J].
Inoue, S ;
Egashira, K ;
Ni, WH ;
Kitamoto, S ;
Usui, M ;
Otani, K ;
Ishibashi, M ;
Hiasa, K ;
Nishida, K ;
Takeshita, A .
CIRCULATION, 2002, 106 (21) :2700-2706
[8]   A DIMETHYLNITROSAMINE-INDUCED MODEL OF CIRRHOSIS AND PORTAL-HYPERTENSION IN THE RAT [J].
JENKINS, SA ;
GRANDISON, A ;
BAXTER, JN ;
DAY, DW ;
TAYLOR, I ;
SHIELDS, R .
JOURNAL OF HEPATOLOGY, 1985, 1 (05) :489-499
[9]   A MORPHOLOGICAL-STUDY OF THE EARLY STAGES OF HEPATIC-FIBROSIS INDUCED BY LOW-DOSES OF DIMETHYLNITROSAMINE IN THE RAT [J].
JEZEQUEL, AM ;
MANCINI, R ;
RINALDESI, ML ;
MACARRI, G ;
VENTURINI, C ;
ORLANDI, F .
JOURNAL OF HEPATOLOGY, 1987, 5 (02) :174-181
[10]   Chemokines - Chemotactic cytokines that mediate inflammation [J].
Luster, AD .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (07) :436-445